A team from the Technical University of Denmark (DTU) and British startup ORCA Computing demonstrated how quantum computing can enhance generative AI models for drug discovery.

By combining a quantum computer with traditional processors, they generated novel peptides capable of binding to specific proteins, a critical step in vaccine development.

The project, funded through spare time and leftover project budgets, showed that quantum-enhanced AI produced more successful peptides than classical models, particularly where training data was scarce.Researchers highlighted the potential to accelerate personalized immunotherapies and improve drug efficacy for understudied populations.

However, challenges remain, including the limited scale of current quantum computers and the need for diverse genetic data to address disparities in medical research.

The study marks a near-term commercial application for quantum technology, with potential extensions to synthetic antidotes for snakebite venom and other neglected diseases.